Danielle Sullivan
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 5%
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
Papers in
- Oncology 14
- PARP inhibition in cancer therapy 10
- Cancer Treatment and Pharmacology 4
-
- Lung Cancer Treatments and Mutations 4
- Advanced Breast Cancer Therapies 2
- Co-authors
- David Maag (9 shared papers)Mark D. McKee (6 shared papers)Mehra Golshan (6 shared papers)Sibylle Loibl (6 shared papers)Charles E. Geyer (6 shared papers)Otto Metzger (5 shared papers)Kamran Diba (1 shared paper)Norman Wolmark (5 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Gynecologic Oncology (2 papers)Journal of Thoracic Oncology (2 papers)Journal of Hepatology (2 papers)Gastroenterology (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Danielle Sullivan
27 papers receiving 1.2k citations
Danielle Sullivan's Hit Papers
Peers
Comparison fields: 5 of 76
- Cancer Research 345
- Oncology 597
- Cellular and Molecular Neuroscience 195
- Cognitive Neuroscience 204
- Pulmonary and Respiratory Medicine 142
Countries citing papers authored by Danielle Sullivan
This map shows the geographic impact of Danielle Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Sullivan more than expected).
Fields of papers citing papers by Danielle Sullivan
This network shows the impact of papers produced by Danielle Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Sullivan. The network helps show where Danielle Sullivan may publish in the future.
Co-authors
The 25 scholars most cited alongside Danielle Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial Hit paper breakdown → | 2018 | 545 |
| 2 | 2011 | 228 | |
| 3 | 2020 | 94 | |
| 4 | 2018 | 62 | |
| 5 | 2016 | 56 | |
| 6 | 2017 | 49 | |
| 7 | 2018 | 48 | |
| 8 | 2018 | 24 | |
| 9 | 2013 | 23 | |
| 10 | 2018 | 16 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 9 | |
| 13 | 2019 | 8 | |
| 14 | 2017 | 7 | |
| 15 | 2015 | 7 | |
| 16 | 2021 | 7 | |
| 17 | 2016 | 4 | |
| 18 | Abstract 12621: Efficacy and Tolerability of Long-Term Treatment With AMG 145 in Patients With Statin Intolerance | 2013 | 2 |
| 19 | 2020 | 2 | |
| 20 | 2017 | 2 |
About Danielle Sullivan
Danielle Sullivan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Genetics and Reproductive Medicine, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (10 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Hepatitis C virus research (3 papers), DNA Repair Mechanisms (2 papers), BRCA gene mutations in cancer (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Cancer Research (345 citations), Oncology (597 citations), Cellular and Molecular Neuroscience (195 citations), Cognitive Neuroscience (204 citations) and Pulmonary and Respiratory Medicine (142 citations). Danielle Sullivan has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include David Maag, Mark D. McKee, Mehra Golshan, Sibylle Loibl, Charles E. Geyer, Otto Metzger, Kamran Diba, Norman Wolmark, Hope S. Rugo and Jens Huober. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Journal of Thoracic Oncology, Journal of Hepatology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.